{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:29:37Z","timestamp":1791523777702,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070628"],"award-info":[{"award-number":["82070628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["GXXT-2019-045"],"award-info":[{"award-number":["GXXT-2019-045"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["GXXT-2020-025"],"award-info":[{"award-number":["GXXT-2020-025"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["GXXT-2020-063"],"award-info":[{"award-number":["GXXT-2020-063"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["KJ2019A0233"],"award-info":[{"award-number":["KJ2019A0233"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.phrs.2021.105926","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T18:22:44Z","timestamp":1633458164000},"page":"105926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl4-induced liver fibrosis"],"prefix":"10.1016","volume":"174","author":[{"given":"Hong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105926_bib1","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","article-title":"Nanotechnology applications for the therapy of liver fibrosis","volume":"20","author":"Giannitrapani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2021.105926_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Geaand","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phrs.2021.105926_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campanaand","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.phrs.2021.105926_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29881","article-title":"Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis","volume":"68","author":"Qu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.29885","article-title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2","volume":"68","author":"Lan","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib6","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2021.105926_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152809789352230","article-title":"Monocytes and macrophages as cellular targets in liver fibrosis","volume":"8","author":"Heymann","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.phrs.2021.105926_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2021.105926_bib10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib11","first-page":"159","article-title":"SOCS1: regulator of T cells in autoimmunity and cancer","volume":"410","author":"Ilangumaran","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.phrs.2021.105926_bib12","doi-asserted-by":"crossref","unstructured":"J. Ying, X. Qiu, Y. Lu, and M. Zhang, SOCS1 and its Potential Clinical Role in Tumor, Pathology oncology research: POR 25 (2019) 1295\u20131301.","DOI":"10.1007\/s12253-019-00612-5"},{"key":"10.1016\/j.phrs.2021.105926_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154733","article-title":"Hepatocyte growth control by SOCS1 and SOCS3","volume":"121","author":"Khan","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2021.105926_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.07.032","article-title":"Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis","volume":"124","author":"Mafanda","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2021.105926_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","article-title":"Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis","volume":"54","author":"Um","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2021.105926_bib16","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20031675","article-title":"SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis","volume":"199","author":"Yoshida","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2021.105926_bib17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.toxlet.2013.12.023","article-title":"SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages","volume":"225","author":"Cheng","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2021.105926_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2018.04.108","article-title":"Sennoside A protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1","volume":"500","author":"Le","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2021.105926_bib19","doi-asserted-by":"crossref","first-page":"14558","DOI":"10.1096\/fj.202000494RR","article-title":"Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation","volume":"34","author":"Zhu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2021.105926_bib20","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1007\/s11356-019-07117-3","article-title":"Moneim, Senna alexandrina extract supplementation reverses hepatic oxidative, inflammatory, and apoptotic effects of cadmium chloride administration in rats","volume":"27","author":"Wang","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.phrs.2021.105926_bib21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1189\/jlb.0308173","article-title":"Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury","volume":"84","author":"Holt","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2021.105926_bib22","doi-asserted-by":"crossref","unstructured":"Z. Wei, P. Shen, P. Cheng, Y. Lu, A. Wang, and Z. Sun, Gut Bacteria Selectively Altered by Sennoside A Alleviate Type 2 Diabetes and Obesity Traits, Oxidative medicine and cellular longevity 2020 (2020) 2375676.","DOI":"10.1155\/2020\/2375676"},{"key":"10.1016\/j.phrs.2021.105926_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.apsb.2019.01.014","article-title":"Regulation of microbiota-GLP1 axis by sennoside A in diet-induced obese mice","volume":"9","author":"Le","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2021.105926_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/287247","article-title":"Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity?","volume":"2009","author":"Morales","year":"2009","journal-title":"J. Toxicol."},{"key":"10.1016\/j.phrs.2021.105926_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyamaand","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2021.105926_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynnand","year":"2010","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.phrs.2021.105926_bib27","article-title":"Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes","volume":"15","author":"Wang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2021.105926_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2353\/ajpath.2009.080632","article-title":"Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice","volume":"174","author":"Mitchell","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2021.105926_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2004.10.005","article-title":"Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats","volume":"128","author":"Imamura","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2021.105926_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.24388","article-title":"Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis","volume":"54","author":"Tarrats","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105926_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s005350050333","article-title":"Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis","volume":"35","author":"Toda","year":"2000","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phrs.2021.105926_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.taap.2012.06.022","article-title":"DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats","volume":"264","author":"Bian","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105926_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2021.105926_bib35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00262-011-1034-2","article-title":"Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4(+) and CD8(+) T cells","volume":"60","author":"Guenterberg","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.phrs.2021.105926_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0501-29","article-title":"SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity","volume":"28","author":"Yoshikawa","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2021.105926_bib37","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1038\/sj.onc.1207787","article-title":"Differential hypermethylation of SOCS genes in ovarian and breast carcinomas","volume":"23","author":"Sutherland","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2021.105926_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/10799893.2011.553836","article-title":"Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley","volume":"31","author":"Hussain","year":"2011","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.phrs.2021.105926_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/ijc.27350","article-title":"Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells","volume":"131","author":"Souma","year":"2012","journal-title":"Int. J. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:41:05Z","timestamp":1762353665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821005107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S1043661821005107"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105926","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl4-induced liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105926"}}